Neuphoria Therapeutics Inc (NEUP) — Capital Reinvestment Ratio
Neuphoria Therapeutics Inc (NEUP) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow ($73.57 Million) in capital expenditures ($3.00). Check how tangible is Neuphoria Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Neuphoria Therapeutics Inc Capital Reinvestment Ratio (2015–2015)
This chart tracks Neuphoria Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Neuphoria Therapeutics Inc cash conversion from operations.
Annual Capital Reinvestment Ratio for Neuphoria Therapeutics Inc (2015–2015)
Year-by-year Capital Reinvestment Ratio for Neuphoria Therapeutics Inc from 2015 to 2015. See cash generation quality of Neuphoria Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.17x | $4.94 Million | $846.26K | — |